GL1X · GenesisL1 explorer

Research workbench

Structure-based design of novel dihydroisoquinoline bace-1 inhibitors that do not engage the catalytic aspartates

Analyse Structure-based design of novel dihydroisoquinoline bace-1 inhibitors that do… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4HZT
Type
protein
Length
393 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
0ZA, ZN
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein39315% helix, 40% strandP56817

Ligands and binding sites

  • 0ZA · 3-{(1S)-1-[(6-chloro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)amino]-2-phenylethyl}-1,2,4-oxadiazol-5(2H)-one · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14450.660.78500ZA
21050.380.7522empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 4HZT · Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage… · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.